|
US4352883A
(en)
|
1979-03-28 |
1982-10-05 |
Damon Corporation |
Encapsulation of biological material
|
|
US4353888A
(en)
|
1980-12-23 |
1982-10-12 |
Sefton Michael V |
Encapsulation of live animal cells
|
|
US4407957A
(en)
|
1981-03-13 |
1983-10-04 |
Damon Corporation |
Reversible microencapsulation of a core material
|
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
CA1237671A
(en)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
IL79289A
(en)
|
1985-07-05 |
1992-01-15 |
Whitehead Biomedical Inst |
Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus
|
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
|
ATE117375T1
(de)
|
1987-09-11 |
1995-02-15 |
Whitehead Biomedical Inst |
Transduktionsveränderte fibroblasten und ihre anwendung.
|
|
US5082670A
(en)
|
1988-12-15 |
1992-01-21 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
|
|
US5185154A
(en)
|
1989-02-02 |
1993-02-09 |
Liposome Technology, Inc. |
Method for instant preparation of a drug containing large unilamellar vesicles
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5084350A
(en)
|
1990-02-16 |
1992-01-28 |
The Royal Institution For The Advance Of Learning (Mcgill University) |
Method for encapsulating biologically active material including cells
|
|
US5618531A
(en)
|
1990-10-19 |
1997-04-08 |
New York University |
Method for increasing the viability of cells which are administered to the brain or spinal cord
|
|
US5219990A
(en)
|
1991-01-28 |
1993-06-15 |
Biogen, Inc. |
Papillomavirus e2 trans-activation repressors
|
|
ATE156344T1
(de)
|
1991-04-25 |
1997-08-15 |
Univ Brown Res Found |
Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
|
|
CA2150803C
(en)
|
1992-12-02 |
2006-01-31 |
Henry Auer |
Controlled release growth hormone containing microspheres
|
|
EP0804249A2
(en)
|
1994-03-15 |
1997-11-05 |
Brown University Research Foundation |
Polymeric gene delivery system
|
|
US5656465A
(en)
|
1994-05-04 |
1997-08-12 |
Therion Biologics Corporation |
Methods of in vivo gene delivery
|
|
PT779806E
(pt)
|
1994-09-09 |
2001-02-28 |
Takeda Chemical Industries Ltd |
Preparacao de libertacao sustentada contendo um sal metalico de um peptido
|
|
PT831787E
(pt)
|
1995-06-07 |
2002-02-28 |
Alkermes Inc |
Composicao para libertacao sustentada da hormona de crescimento humano
|
|
US5677158A
(en)
|
1995-06-07 |
1997-10-14 |
Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
ZA965368B
(en)
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
US6683058B1
(en)
|
1998-04-15 |
2004-01-27 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
|
WO1999061066A2
(en)
|
1998-05-27 |
1999-12-02 |
Avigen, Inc. |
Convection-enhanced delivery of aav vectors
|
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
|
US20020037281A1
(en)
|
2000-05-26 |
2002-03-28 |
Davidson Beverly L. |
Methods of transducing neural cells using lentivirus vectors
|
|
US6555674B2
(en)
|
2000-08-09 |
2003-04-29 |
Nsgene A/S |
JeT promoter
|
|
CN1525866B
(zh)
|
2001-03-28 |
2013-05-29 |
比奥根艾迪克Ma公司 |
神经胚活素多肽的治疗作用
|
|
AU2005229434B2
(en)
|
2004-03-30 |
2010-09-30 |
Nsgene A/S |
Therapeutic use of a growth factor, NsG33
|
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
|
WO2012041328A1
(en)
|
2010-10-01 |
2012-04-05 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
|
JP6145667B2
(ja)
*
|
2011-09-05 |
2017-06-14 |
ホーバ セラピューティクス アンパルトセルスカブ |
アロディニア、痛覚過敏、自発痛、及び幻痛の治療
|